SCHEMBL19895348

SCHEMBL19895348

N#CC(=Cc1cccc(O)c1O)C(N)=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 6/20 0.59
▸ LCK P06239 2/20 0.59
▸ KDM4E B2RXH2 5/20 0.55
▸ MEN1 O00255 3/20 0.55
▸ KMT2A Q03164 3/20 0.55
▸ MAPT P10636 3/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ GAA P10253 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ APEX1 P27695 1/20 0.55
▸ BLM P54132 1/20 0.55
▸ MCL1 Q07820 1/20 0.54
▸ CYP1A2 P05177 3/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ ERBB2 P04626 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ CYP2C9 P11712 2/20 0.52
▸ ADORA2A P29274 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8743681 1.00 EGFR (0.59) EGFRLCKKDM4EMEN1KMT2A
SCHEMBL21457670 0.85 EGFR (0.58) EGFRKDM4EKMT2AALDH1A1HPGD
SCHEMBL21457666 0.85 EGFR (0.58) EGFRKDM4EKMT2AALDH1A1HPGD
SCHEMBL8743687 0.84 MAPT (0.53) EGFRKDM4EMEN1KMT2AMAPT
SCHEMBL21457354 0.80 ADORA2A (0.75) KDM4EMEN1KMT2AMAPTPOLB
SCHEMBL21457357 0.80 ADORA2A (0.75) KDM4EMEN1KMT2AMAPTPOLB
SCHEMBL21457337 0.78 ALDH1A1 (0.57) KDM4EMEN1KMT2AMAPTPOLB
SCHEMBL21457333 0.78 ALDH1A1 (0.57) KDM4EMEN1KMT2AMAPTPOLB
SCHEMBL1388529 0.78 EGFR (0.59) EGFRLCKKDM4EMEN1KMT2A
SCHEMBL1388528 0.78 EGFR (0.59) EGFRLCKKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021231762-A2 COMBINATION THERAPY FOR THE TREATMENT OF TNBC WITH A PI3K PATHWAY INHIBITOR THAT TARGETS PI3KDELTA AND PI3KGAMMA TNBC THE TRUSTEES OF INDIANA UNIVERSITY (US) 2021-11-18 — — WO disclosed
US-9945845-B2 Methods of screening using amphibians BRAENDLI ANDRE W (CH) 2018-04-17 — — US disclosed
US-20180059097-A1 METHODS OF SCREENING USING AMPHIBIANS BRAENDLI ANDRE W (CH) 2018-03-01 — — US disclosed
Send feedback